Literature DB >> 34877038

Subaxial cervical Castleman's disease: A rare cause of myelopathy.

Abhinandan Reddy Mallepally1,2, Amrit Gantaguru1, Nandan Marathe1, Tarush Rustagi1, Alhad Mulkalwar2, Kalidutta Das1.   

Abstract

BACKGROUND: Castleman's disease (CD) is a rare lymphoproliferative disease of unknown origin which rarely affects the spine. Here, we present CD involving a lytic, destructive C3 lesion with extension into the spinal canal contributing to upper cervical cord compression. Notably, the lesion mimicked other primary bone lesions, metastatic tumors, and/or lymphoma. CASE DESCRIPTION: A 52-year-old male presented with progressive quadriparesis (i.e. weakness, instability of gait) and loss of dexterity in both hands over 2 weeks. The MRI, X-ray, and CT scans revealed a destructive lytic lesion involving the C3 vertebral body (i.e. including both anterior and posterior elements). The patient underwent a C3 total and C4 partial laminectomy followed by a C2-C4/5 instrumented fusion (i.e. included C2 pedicle screws/laminar screws, and C4/C5 lateral mass fixation). Histopathology showed a lymphoproliferative disorder with follicles of different sizes, central abnormal germinal structures, and a Mantle zone (i.e. expanded germinal centre with concentric layering with an "onionskin" appearance). These findings were all consistent with the diagnosis of CD (i.e. hyaline-vascular type).
CONCLUSION: CD, a rare lymphoproliferative disease of unknown origin rarely affects the spine. Here, we presented a 52-year-old male with a C3 lytic lesion resulting in C3/4 cord compression that favorably responded to a C3/4 laminectomy with posterior instrumented fusion. Copyright:
© 2021 Surgical Neurology International.

Entities:  

Keywords:  Castleman’s; Cervical spine; Lymph node; Myelopathy

Year:  2021        PMID: 34877038      PMCID: PMC8645467          DOI: 10.25259/SNI_909_2021

Source DB:  PubMed          Journal:  Surg Neurol Int        ISSN: 2152-7806


INTRODUCTION

Castleman’s disease (CD) is a rare lymphoproliferative disease of unknown origin that generally affects lymph nodes, rarely the chest, neck, abdomen, pelvis, axilla, sometimes the lung, parotid gland, pancreas, and spine.[10] Other terms for CD include - angiofollicular hyperplasia, localized nodal hyperplasia, giant lymph node hyperplasia, angiomatous lymphoid hamartoma, follicular lymphoreticuloma, and CD. The differential diagnoses for CD include - infection, malignancy, autoimmune, and/or collagen vascular disease. Eight other cases of spinal CD [Table 1] were identified by the authors; six of them presented as extradural/intracanalicular masses requiring decompression procedures for the resultant myelopathy, followed by adjuvant radio and/or chemotherapy.[5,7] Here, we present a 52-year-old male with a C3 CD lesion with resultant cord compression/myelopathy who’s favorably responded to a C3-4 laminectomy with C2-C4, 5 posterior fusion.
Table 1:

Literature review of Castleman’s disease involving the spine.

Literature review of Castleman’s disease involving the spine.

CASE DESCRIPTION

A 52-year-old male presented with 2 weeks of a progressive quadriparesis (i.e. loss of dexterity in both hands and lower extremity weakness) and urinary incontinence. He also had cervical lymphadenopathy (i.e. anterior/posterior and post-auricular lymph nodes). On exam, he had 4/5 weakness in both lower extremities, diffuse lower extremity hyper-reflexia with bilateral Babinski responses, and a T2 sensory level (mJOA-10/18).

Radiological studies

The X-rays and CT scan revealed a destructive lytic C2-C4 lesion focused at the C3 level vertebral body (i.e. destructive lytic lesion of anterior/posterior C3, the C2 spinous process, and anterior C4 vertebral body) [Figure 1]. MRI showed multiple enlarged lymph nodes in the neck along with lytic lesions involving C3 (i.e. both anterior and posterior elements). Furthermore, an epidural soft-tissue mass causing spinal cord compression was seen posteriorly at the C3-4 level. Although predominantly dorsal, the lesion wrapped circumferentially around the spinal cord bilaterally. The lesion was isointense to hypointense as compared with the spinal cord on T2 weighted images and hyperintense to cord on the T2-weighted image [Figure 2] The PET CT confirmed increase uptake at C3 alone [Figure 3]. The predominant differential diagnoses included lymphoma or metastatic tumors or infection.
Figure 1:

Anteroposterior (a) and Lateral (b) radiographsshowinglyticexpansilelesion in thepoosteriorelemnts of C3 spinous process with cervical spine in mild kyphosis. Computer tomography images Sagittal (c), Coronal (d) andAxial images (e) showing lytic expansile lesion involving C3 vertebral body and posterior elements more onto the left side.

Figure 2:

Sagittal section of STIR (a), T2 weighted (b) and T1 weighted (c) images showing high signal intensity on Stir images in C3 vertebral body and posterior elements and hypointense signal on T1 weighted images. Cord compression due to epidural mass effect can be appreciated from posterior aspect. (d) Axial T2 weighted images at C3 vertebral body level showing destruction of Spinous process and left sided lamina and lateral mass with epidural tissue compressing and displacing the spinal cord.

Figure 3:

PET-CT scan images showing solitary lesion involving the C3 vertebral body with destruction of posterior and anterior bony elements with hot spots noted in C3 body, spinous process, lamina and lateral mass more towards the left.

Anteroposterior (a) and Lateral (b) radiographsshowinglyticexpansilelesion in thepoosteriorelemnts of C3 spinous process with cervical spine in mild kyphosis. Computer tomography images Sagittal (c), Coronal (d) andAxial images (e) showing lytic expansile lesion involving C3 vertebral body and posterior elements more onto the left side. Sagittal section of STIR (a), T2 weighted (b) and T1 weighted (c) images showing high signal intensity on Stir images in C3 vertebral body and posterior elements and hypointense signal on T1 weighted images. Cord compression due to epidural mass effect can be appreciated from posterior aspect. (d) Axial T2 weighted images at C3 vertebral body level showing destruction of Spinous process and left sided lamina and lateral mass with epidural tissue compressing and displacing the spinal cord. PET-CT scan images showing solitary lesion involving the C3 vertebral body with destruction of posterior and anterior bony elements with hot spots noted in C3 body, spinous process, lamina and lateral mass more towards the left.

Surgery

In view of a Spinal Instability Neoplastic Score of 14, the evidence of spinal cord compression and likely instability, the patient underwent a C3-4/laminectomy with C2-4/5 posterior fusion. At surgery, the posterior cervical paraspinal musculature infiltrated by tumor and had to be removed. A novel “three rod construct” fusion was performed that included C2 pedicle screws, laminar screws, a C4 left pedicle screw with lateral mass fixation of C4 and C5 [Figure 4]. The frozen section diagnosis was lymphoma. Postoperatively, the patient had complete neurological recovery except for bladder dysfunction.
Figure 4:

Anteroposterior and lateral radiographs in the immediate post-operative period showing resection of posterior elements and laminectomy at C3 and fixation with a novel three rod construct utilizing C2 and C4 (left) pedicle screws and C2 laminar screw with C4, C5 lateral mass screws.

Anteroposterior and lateral radiographs in the immediate post-operative period showing resection of posterior elements and laminectomy at C3 and fixation with a novel three rod construct utilizing C2 and C4 (left) pedicle screws and C2 laminar screw with C4, C5 lateral mass screws.

Histopathology

Histopathology was consistent with a lymphoproliferative disorder (i.e. with follicles of different size with abnormal germinal structures at their centres with hyaline-vascular or “burnt-out” appearances) [Figure 5]. The Mantle zone was expanded with concentric layering and an “onion skin” appearance. Immunohistochemical stains revealed a normal distribution of B and T cells and intact germinal centres with a normal distribution of dendritic reticulum cells. The final diagnosis was CD of hyaline-vascular type.
Figure 5:

Haematoxylin and Eosin photomicrographs demonstrating (a) a germinal centre with hyaline deposits and penetrated by sclerotic blood vessels and typical concentric rings of small lymphocytes in an onion skin composition. (b) Dense lymphoid infiltrate with hyperplastic lymphoid follicles with small, hyalinised germinal centres, mantle cell hyperplasia. (c) Low power view of the tissue showing vascular and lymphoid proliferation hyalinised blood vessels penetrating radially into the follicles.

Haematoxylin and Eosin photomicrographs demonstrating (a) a germinal centre with hyaline deposits and penetrated by sclerotic blood vessels and typical concentric rings of small lymphocytes in an onion skin composition. (b) Dense lymphoid infiltrate with hyperplastic lymphoid follicles with small, hyalinised germinal centres, mantle cell hyperplasia. (c) Low power view of the tissue showing vascular and lymphoid proliferation hyalinised blood vessels penetrating radially into the follicles.

Adjuvant therapy

The patient was started on methylprednisolone for the lymphadenopathy, and diagnosis of CD. This was followed by radiotherapy (total dose 3960cGy in 22 fractions).

Follow-up 1 year later

At the last follow-up 1 year later, patient remained asymptomatic without evidence of lesion progression [Figure 6].
Figure 6:

Follow-up T2 weighted (a) and T1 weighted (b) sagittal MR images showing adequate decompression of cord and axial MRI (c) showing adequate resolution of tumour. Coronal (d) and sagittal (e) images showing resolution of tumorous mass and lateral (f) and anteroposterior (g) radiographs showing no signs of implant failure.

Follow-up T2 weighted (a) and T1 weighted (b) sagittal MR images showing adequate decompression of cord and axial MRI (c) showing adequate resolution of tumour. Coronal (d) and sagittal (e) images showing resolution of tumorous mass and lateral (f) and anteroposterior (g) radiographs showing no signs of implant failure.

DISCUSSION

CD is a rare lymphoproliferative disorder that is histologically categorized as a benign, hyaline-vascular type, representing approximately 80–90% of cases; the remaining 10–20% are aggressive multifocal form - plasma cell type lesions.[2,3] Our patient had the more common hyaline-vascular form of CD. CD lesions on MR typically appear hypointense on T1-weighted images, and hyperintense on T2-weighted studies.[9] In this case, the MR showed CD tumor involving both anterior and posterior elements of C3 vertebrae and also seen epidural soft-tissue mass causing spinal cord compression at C3-4 posteriorly. The lesion was predominantly dorsal and wrapped around the spinal cord bilaterally. On CT, extensive destructive bony-lytic lesions are often better appreciated involving the posterior elements/vertebral bodies rather than anterior vertebrae. The treatment modalities for CD include surgical excision for single lymph node involvement. Complete surgical resection generally offers complete cure in those with a localized variant, while those with more extensive diffuse unresectable lesions typically warrant additional chemotherapy, immunotherapy, and/or radiation therapy. Histopathology of CD may resemble other conditions such as lymphoma, autoimmune disorders like rheumatoid arthritis, Sjögren’s syndrome, monoclonal gammopathy, and acquired immunodeficiency syndrome. A definitive diagnosis of CD requires pathological-histological confirmation (i.e. biopsy or tumor resection). Those patients with the localized form may be treated with local resection or radiation therapy[8] as well as systemic chemotherapy.[1] Recent developments suggest a major role of interleukin-6 (IL-6) in the treatment of CD. MCD treatment may include prednisolone or novel human-mouse chimeric immunoglobulin G1κ monoclonal antibody against human IL-6 siltuximab.[4,6] Sometimes, it may require treatment like lymphoma with R-CHOP regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). Radiotherapy may be necessary for rare cases that are not surgically resectable.[9]

CONCLUSION

CD rarely involves the spine. Here, it presented involving the C2-C4 levels (i.e. focused at C3) with cord compression warranting a C3/4 laminectomy and C2-C4/5 posterior fusion.
  10 in total

1.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

2.  Castleman's disease of the sacral spine.

Authors:  Ross McMillan; C Rory Goodwin; Wesley Hsu; James Pendleton; Edward McCarthy; Jean-Paul Wolinsky; Allan J Belzberg
Journal:  Clin Neurol Neurosurg       Date:  2011-11-21       Impact factor: 1.876

3.  Castleman's disease manifesting in the central nervous system: case report with immunological studies.

Authors:  P G Gianaris; J E Leestma; L J Cerullo; A Butler
Journal:  Neurosurgery       Date:  1989-04       Impact factor: 4.654

4.  Remission of giant lymph node hyperplasia with anemia after radiotherapy.

Authors:  D D Weisenburger; R L DeGowin; P Gibson; J O Armitage
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

5.  [Successful treatment of pure red cell aplasia complicated by multicentric Castleman disease with prednisolone].

Authors:  Kosuke Arai; Junichi Mukae; Megumi Akiyama; Jiro Kumagai; Koh Yamamoto
Journal:  Rinsho Ketsueki       Date:  2020

6.  Castleman's disease of the leptomeninges. Report of three cases.

Authors:  G S Severson; D S Harrington; D D Weisenburger; R D McComb; J H Casey; B R Gelber; B Varet; R Abelanet; H H Rappaport
Journal:  J Neurosurg       Date:  1988-08       Impact factor: 5.115

7.  Multicentric hyaline-vascular type Castleman disease presenting as an epidural mass causing paraplegia: a case report.

Authors:  Ajay Gupta; Lalit Kumar; Ashok Karak; Sanjay Thulkar; Ruchi Rastogi; Sahibinder Bhatti
Journal:  Clin Lymphoma Myeloma       Date:  2009-06

8.  Castleman disease of the spine mimicking a nerve sheath tumor. Case report.

Authors:  Michael A Finn; Meic H Schmidt
Journal:  J Neurosurg Spine       Date:  2007-05

9.  International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.

Authors:  Frits van Rhee; Peter Voorhees; Angela Dispenzieri; Alexander Fosså; Gordan Srkalovic; Makoto Ide; Nikhil Munshi; Stephen Schey; Matthew Streetly; Sheila K Pierson; Helen L Partridge; Sudipto Mukherjee; Dustin Shilling; Katie Stone; Amy Greenway; Jason Ruth; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Raj Jayanthan; Elaine S Jaffe; Heather Leitch; Naveen Pemmaraju; Amy Chadburn; Megan S Lim; Kojo S Elenitoba-Johnson; Vera Krymskaya; Aaron Goodman; Christian Hoffmann; Pier Luigi Zinzani; Simone Ferrero; Louis Terriou; Yasuharu Sato; David Simpson; Raymond Wong; Jean-Francois Rossi; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Eric Oksenhendler; David C Fajgenbaum
Journal:  Blood       Date:  2018-09-04       Impact factor: 25.476

10.  The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman's disease.

Authors:  Gi-June Min; Young-Woo Jeon; Sung-Soo Park; Silvia Park; Seung-Hawn Shin; Seung-Ah Yahng; Jae-Ho Yoon; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Hee-Je Kim; Chang-Ki Min; Dong-Wook Kim; Jong-Wook Lee; Seok-Goo Cho
Journal:  Korean J Intern Med       Date:  2020-02-24       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.